Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Genomics, Isis to Co-develop microRNA-based Drugs for Liver Cancer

NEW YORK, Feb. 22 (GenomeWeb News) - Isis Pharmaceuticals and Rosetta Genomics plan to co-discover and -develop antisense drugs that regulate microRNAs for the treatment of hepatocellular carcinoma, the companies said today.

 

The alliance will rely on Rosetta's database of miRNA genes and Isis' expertise in oligonucleotide chemistry and antisense drug discovery and development.

 

Financial terms of the deal were not disclosed.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.